10 Semaglutide has demonstrated significant cardiovascular benefits, particularly in reducing the risk of major adverse cardiovascular events, such as heart attacks and strokes
From a behavioral health standpoint, these changes can produce maladaptive thought patterns such as all-or-nothing thinking, catastrophizing weight regain, and negative self-judgment
A separate Medicare GLP1 payment demonstration begins July 2026, under which eligible beneficiaries pay $50 per month for GLP1 medications
42-43, FF, Modern Comple, Sai Road, Baddi, Distt
Substantial weight regain after discontinuation highlights the need to shift focus from short-term weight loss to long-term behavioral stabilization